Alkem Laboratories Ltd has seen its US business double in size over the past four years, from FY17 to FY21, “led by new product launches and market share gain in existing products.” The Indian company observed that in the fourth quarter of its most recent financial year alone, its US sales contributed 25.1% of the company’s total. However, Alkem acknowledged that it saw its US sales drop by 10.4% to INR5.4bn ($75m) for the quarter ending 31 March 2021.
On a yearly basis, Alkem reported growth of 11.4% in its US business to INR24.5bn in FY21, compared to INR22.0bn...



